Buren advises Netherlands Translational Research Center

Buren advises the Netherlands Translational Research Center B.V. (NTRC), operational at the Life Sciences Park Oss, with its first round of financing by the Brabant Life Sciences Seed Fund and the Spin-Off Fund of the Province Noord-Brabant.

NTRC develops innovative medicines in close cooperation with academical centers in the Netherlands. In this way NTRC translates the unique knowledge of the academical centers in candidate medicines and thereby builds a bridge between universities and the pharmaceutical industry.

Key contacts

Paul Deloo

Partner | Civil law notary
Send me an e-mail
+31 (0)20 333 8393

Team

Paul Deloo

Partner | Civil law notary
Send me an e-mail
+31 (0)20 333 8393

Related news & updates

Strategic move: BUREN relocates The Hague office to 'De Haagsche Zwaan'

The Hague, April 8, 2024 – BUREN proudly announces that as of July 1, 2024, it will be moving to a new office space in the iconic building more …

Venture capital: investing in the growth of startups

In the world of investments, one specific sector attracts the attention of most start-ups: venture capital. In this sector, investors invest money in young companies to finance their growth. more …

Sanctions - Now what?

Russia-related sanctions are becoming more and more extensive. How can a company ensure that its business is not affected by sanctions? And how do judges look at compliance with those sanctions? more …

BUREN ESG webinar | ESG in the Netherlands - from a legal and tax perspective | 5 July 2022

In BUREN's ESG webinar, our Corporate, Banking & Finance and Tax teams will give you more insight into the impact of ESG more …